Skip to content

Evidence Hub

Publication
Jul 25, 2024

Understanding the Economic Burden of RSV-Associated Hospitalizations in Adults

Respiratory syncytial virus (RSV) poses significant health risks, particularly for older ...
Start Reading
Publication
Jul 24, 2024

Comparing the Effectiveness of a Third COVID-19 Vaccine Dose in Older Adults

As the COVID-19 pandemic continues to evolve, the importance of booster doses in ...
Start Reading
Podcast
Jul 19, 2024

Podcast: Top leadership share stories of their childhood and how it guided them into leadership roles later in life

In this episode of the Executive Leaders Radio Podcast, John Ferretti of CODi, Carolyn ...
Start Reading
Blog
Jul 17, 2024

Efficient Synthesis of Complex Health Data

Blog authored by Lucy Mosquera (Sr. Director, Generate Operations and Data Science) and ...
Start Reading
Blog
Jun 26, 2024

Advancing SMA Treatment: How Real-World Evidence Supports Regulatory Decisions

Spinal Muscular Atrophy (SMA) is a rare and debilitating neuromuscular disease affecting ...
Start Reading
Blog
Jun 20, 2024

Quality, Rigor, and Transparency: The RWE Imperative

Over the past year, news stories have focused on high-profile missteps or fraud in the ...
Start Reading
Blog
Jun 18, 2024

The Evolving Role of Observational Studies in Healthcare: Enhancing Payer Utility and Impact

Blog authored by Ashley Jaksa (VP, Scientific Strategy & Partnerships) and Pat Arena ...
Start Reading
Publication
Jun 4, 2024

The potential role of real-world evidence in Centers for Medicare & Medicaid Services’ future price negotiations: Recommendations for a robust framework

In this article, authors Ashley Jaksa (VP, Scientific Strategy & Partnerships, ...
Start Reading
On-Demand Webinar
May 22, 2024

Clinical Development Webinar | June 20, 2024

Watch the webinar on-demand: Strategic Use of Real-World Data to Support Clinical ...
Start Reading
Blog
May 6, 2024

Navigating the European Union's Medical Device Regulation (MDR)

On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became ...
Start Reading
On-Demand Webinar
May 2, 2024

De-ID Complex Data Webinar | June 6, 2024

Watch the webinar Unlocking Real-World Data for Analysis: Experiences De-identifying ...
Start Reading
On-Demand Webinar
May 1, 2024

Oncology RWD Webinar | May 29, 2024

Join the webinar The Goldilocks problem in oncology RWD: choosing the data that’s 'just ...
Start Reading
On-Demand Webinar
Apr 22, 2024

Synthetic Data Webinar | May 15, 2024

Watch the webinar The Replicability of Analysis Results Using Synthetic Clinical Trial ...
Start Reading
Blog
Apr 20, 2024

How to unleash the replicability potential of synthetic data

In today's data-driven world, the need for innovative solutions to evolve alongside the ...
Start Reading
Case Study
Apr 19, 2024

Case Study: Enhancing clinical trial data sharing with synthetic datasets

Unlock the future of research with our groundbreaking approach to privacy-preserving data ...
Start Reading
Case Study
Apr 19, 2024

Case Study. Data Guardian: Securing Enterprise Health Data through an Advanced Risk Assessment and De-Identification Solution

Our case study explores how our client, a leading American retail company, and its ...
Start Reading
Case Study
Apr 19, 2024

Case Study: Unlock the Replicability Power of Synthetic Data in Health Research – with Practical and Reliable Guidelines

Embark on a journey to harness the full potential of Synthetic Data Generation (SDG) ...
Start Reading
Whitepaper
Apr 19, 2024

Whitepaper: RWE as Confirmatory Evidence for Accelerated Approvals

Since 1992, the FDA has paved the way for life-saving medicines to reach patients swiftly ...
Start Reading
Blog
Apr 3, 2024

Key Takeaways from the public workshop, “Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology”

By Inish O’Doherty and Purva Jain
Start Reading
Publication
Mar 24, 2024

An evaluation of the replicability of analyses using synthetic health data

This paper published in Scientific Reports describes a study evaluating the replicability ...
Start Reading
Blog
Mar 21, 2024

FDA releases draft guidance on non-interventional studies for drug and biological products

The Food and Drug Administration (FDA) continues to advance its RWE Program, this time ...
Start Reading
Presentation
Dec 13, 2023

Ten Things I have Learned About Synthetic Data Generation

Khaled El Emam, SVP & GM, Replica Analytics
Start Reading
Blog
Dec 7, 2023

Aetion’s comments to FDA on recent draft guidance on the substantial evidence standard

This week, Aetion submitted a letter to FDA commenting on the Agency’s recent draft ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 2: Perspectives from Health Regulators

Title: High-Fidelity Synthetic Data Applications for Data Augmentation
Start Reading